Compugen Ltd
NASDAQ:CGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Compugen Ltd
NASDAQ:CGEN
|
IL |
|
D
|
Diageo PLC
F:GUIA
|
UK |
|
Geberit AG
F:GBRF
|
CH |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
KR |
|
B
|
British American Tobacco PLC
DUS:BMT
|
UK |
|
G
|
Greif Inc
XBER:GR3
|
US |
|
W
|
Waters Corp
DUS:WAZ
|
US |
|
Brambles Ltd
ASX:BXB
|
AU |
|
Alpha Services and Holdings SA
F:ACBC
|
GR |
|
Solaredge Technologies Inc
NASDAQ:SEDG
|
IL |
|
B
|
Bank of New York Mellon Corp
F:BN9
|
US |
|
V
|
Vext Science Inc
XMUN:VV5
|
CA |
|
Renault SA
MIL:1RNO
|
FR |
|
Vianet Group PLC
F:AS2
|
UK |
|
E
|
Entergy Corp
DUS:ETY
|
US |
|
N
|
National Grid PLC
DUS:NNGF
|
UK |
|
T
|
Toyota Industries Corp
XMUN:TAH
|
JP |
|
C
|
Construction Partners Inc
F:CQY
|
US |
Wall St Price Targets
CGEN Price Targets Summary
Compugen Ltd
According to Wall Street analysts, the average 1-year price target for CGEN is 4.69 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CGEN's stock price target?
Price Target
4.69
USD
According to Wall Street analysts, the average 1-year price target for CGEN is 4.69 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Compugen Ltd?
Projected CAGR
-24%
The compound annual growth rate for Revenue over the next 3 years is -24%.
What is the Gross Profit forecast for Compugen Ltd?
Projected CAGR
-32%
The compound annual growth rate for Gross Profit over the next 3 years is -32%.
